In addition, XLLXF reverses the EMT by increasing E-cadherin expression and decreasing the levels of Vimentin, Twist1, and VE-cadherin, thus preventing tumor cells from acquiring an endothelial-like phenotype. This evidence concerns the gene CDH1 and neoplasm.